| abstract |
Antisense compounds and methods for treating, preventing, or ameliorating diseases, disorders, or conditions associated with apo (a) or Lp (a) by reducing apo (a) are described herein. Certain diseases, disorders or conditions associated with apo (a) or Lp (a) include inflammation, cardiovascular and / or metabolic diseases, disorders or conditions. The antisense compounds described herein can be used to treat such diseases, disorders or conditions in an individual in need thereof. |